Efficacy and safety of cladribine: Subcutaneous versus intravenous administration in hairy cell leukemia

被引：0
|
作者：
Yakout, T. [1 ]
Mosaad, G. [2 ]
Namour, A. [2 ]
Malek, R. [3 ]
Khorshid, O. [2 ]
机构：
[1] Cairo Oncol Ctr, Cairo, Egypt
[2] Natl Canc Inst, Cairo, Egypt
[3] Cairo Univ, Fac Med, Cairo, Egypt
来源：
EUROPEAN JOURNAL OF CANCER | 2013年 / 49卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3652
引用
收藏
页码：S852 / S852
页数：1
相关论文
共 50 条
  • [41] Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol
    Pablo Espinosa Lara
    Virginia Quirós Redondo
    Marta Aguado Lobo
    José Jiménez-Reyes
    Annals of Hematology, 2017, 96 : 1209 - 1210
  • [42] Purpuric exanthema in a patient with hairy cell leukemia treated with cladribine and allopurinol
    Espinosa Lara, Pablo
    Quiros Redondo, Virginia
    Aguado Lobo, Marta
    Jimenez-Reyes, Jose
    ANNALS OF HEMATOLOGY, 2017, 96 (07) : 1209 - 1210
  • [43] Phase II clinical study of cladribine in the treatment of hairy cell leukemia
    Machii, T
    Chou, T
    Suzuki, M
    Ohe, Y
    Katagiri, S
    Kitano, K
    Fujiyama, Y
    Izumi, T
    Shimazaki, C
    Nanba, K
    Ohashi, Y
    Kitani, T
    INTERNATIONAL JOURNAL OF HEMATOLOGY, 2005, 82 (03) : 230 - 235
  • [44] Cladribine with Immediate Rituximab for the Treatment of Patients with Variant Hairy Cell Leukemia
    Kreitman, Robert J.
    Wilson, Wyndham
    Calvo, Katherine R.
    Arons, Evgeny
    Roth, Laura
    Sapolsky, Jeffrey
    Zhou, Hong
    Raffeld, Mark
    Stetler-Stevenson, Maryalice
    CLINICAL CANCER RESEARCH, 2013, 19 (24) : 6873 - 6881
  • [45] Cladribine treatment of a patient with hairy cell leukemia and concomitant multiple sclerosis
    Hilbe, W
    Berger, T
    Konwalinka, G
    Thaler, J
    ACTA HAEMATOLOGICA, 1999, 102 (02) : 99 - 100
  • [46] Progressive Multifocal Leukoencephalopathy after Cladribine Treatment for Hairy Cell Leukemia
    Aletti, Marc
    Faivre, Antony
    Wybrecht, Delphine
    Couturier, Claire Chandre Aymes
    Bounolleau, Pierre
    Alla, Philippe
    NEUROLOGY, 2011, 76 (09) : A28 - A28
  • [47] Secondary acute myeloid leukemia following successful treatment of hairy cell leukemia with cladribine
    Seshadri, P
    LEUKEMIA RESEARCH, 2000, 24 (07) : 637 - 637
  • [48] Efficacy of rituximab in hairy cell leukemia
    Malfuson, Jean-Valere
    Doghmi, Kamal
    Fagot, Thierry
    Souleau, Bertrand
    de Revel, Thierry
    Nedellec, Gerard
    PRESSE MEDICALE, 2006, 35 (05): : 801 - 802
  • [49] Non-inferiority efficacy analysis of natalizumab (TYSABRI) subcutaneous versus intravenous administration
    Mealli, F.
    Mattei, A.
    Mariottini, A.
    Massacesi, L.
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 : 247 - 247
  • [50] 2-chlorodeoxyadenosine (cladribine) in the treatment of hairy cell leukemia and hairy cell leukemia variant: 7-year experience in Poland
    Robak, T
    Blasinska-Morawiec, M
    Blonski, J
    Hellmann, A
    Halaburda, K
    Konopka, L
    Kotlarek-Haus, S
    Potoczek, S
    Hansz, J
    Dmoszynska, A
    Urasinski, I
    Zdziarska, B
    Dwilewicz-Trojaczek, J
    Holowiecki, J
    Skotnicki, AB
    EUROPEAN JOURNAL OF HAEMATOLOGY, 1999, 62 (01) : 49 - 56
12345